Cue Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.About CUE
Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease.
CEODaniel R. Passeri
CEODaniel R. Passeri
Employees41
Employees41
HeadquartersBoston, Massachusetts
HeadquartersBoston, Massachusetts
Founded2014
Founded2014
Employees41
Employees41
CUE Key Statistics
Market cap49.20M
Market cap49.20M
Price-Earnings ratio-0.95
Price-Earnings ratio-0.95
Dividend yield—
Dividend yield—
Average volume200.36K
Average volume200.36K
High today$0.6499
High today$0.6499
Low today$0.61
Low today$0.61
Open price$0.643
Open price$0.643
Volume23.94K
Volume23.94K
52 Week high$1.99
52 Week high$1.99
52 Week low$0.45
52 Week low$0.45
People also own
Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.